Bardep-D 20 Tablet
By Bardep-D
Rx
10 Tablet in a Strip

Composition
Duloxetine(20mg)

Manufacturer - Biologic Psychotropics India Pvt Ltd
Near UCO Bank, Nahan Road, Kalaamb, Sirmaur-173030, Himachal Pradesh, India

Expires on or after
October, 2025

liver
According to the information provided, Bardep-D 20 Tablet may not be safe for individuals with liver disease and should be avoided. It is important to notify your doctor if you have any existing liver conditions before using Bardep-D 20 Tablet. Your doctor will then assess the advantages and possible risks before deciding if this medication is suitable for you. It is advised to seek medical advice before using Bardep-D 20 Tablet in case of liver problems.

kidney
Bardep-D 20 Tablet should be used carefully in severe kidney disease, as dose adjustment might be necessary. Consult your doctor for guidance. Mild to moderate kidney disease may not require dose adjustment with Bardep-D 20 Tablet. Bardep-D 20 Tablet is not recommended for severe kidney disease.

alcohol
It is not safe to drink alcohol while using Bardep-D 20 Tablet. Mixing alcohol with this medication can lead to increased side effects like confusion, drowsiness, and difficulty concentrating. Limit alcohol intake while taking this medicine.

driving
When taking Bardep-D 20 Tablet, be cautious as it may reduce alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects to ensure safety on the road. Bardep-D 20 Tablet can also cause sleepiness, impacting driving ability.

pregnancy
Bardep-D 20 Tablet should not be used during pregnancy as it may have harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing it. Consult your doctor before using Bardep-D 20 Tablet.

breastfeeding
Bardep-D 20 Tablet may not be safe for use while breastfeeding. Limited data suggests it could pass into breastmilk and harm the baby. Consult your doctor to determine if Bardep-D 20 Tablet is suitable for nursing mothers.
Habit Forming | No |
Chemical Class | Naphthalene Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Serotonin-norepinephrine reuptake inhibitors (SNRIs) |
₹58
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024